Changes in the Urinary Excretion of Metabolites During Treatment with Nitrogen Mustard and Triethylenemelamine
1958

Changes in Urinary Excretion of Metabolites During Cancer Treatment

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): J. Gerbrandy, H. B. A. Hellendoorn

Primary Institution: The Netherlands Cancer Institute, Amsterdam

Hypothesis

The rise of urinary excretion of metabolites depends on the rate of tumor destruction during treatment with cytotoxic drugs.

Conclusion

The study found that the urinary excretion of metabolites increased during treatment with nitrogen mustard and triethylenemelamine, similar to the effects observed with X-ray irradiation.

Supporting Evidence

  • The study observed a close time-relationship between the rise of metabolites and the start of drug treatment.
  • Estimated tumor loss correlated with the urinary excretion of phosphate and clinical measures like body weight.
  • Excretion patterns of metabolites such as phosphate, uric acid, and potassium showed similar trends during treatment.

Takeaway

When cancer patients are treated with certain drugs, their bodies release more waste products, which can help doctors understand how well the treatment is working.

Methodology

The study involved 10 cancer patients who received standardized diets and intravenous injections of nitrogen mustard or triethylenemelamine, with measurements of urinary excretion of various metabolites.

Limitations

The study had a small sample size and the observation period was not long enough for all patients to reach a new equilibrium in metabolite excretion.

Participant Demographics

The participants included 6 patients with Hodgkin's disease, 3 with metastasized carcinoma, and 1 with generalized reticulosarcomatosis.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication